OverviewSuggest Edit

Sareum Holdings discovers and develops innovative drug candidates aimed at cancers and autoimmune diseases. The Company's drug development programmes aim to improve outcomes for patients with serious medical conditions and where current therapies are inadequate. Sareum Holdings develops therapeutic drugs based on its Sareum Kinase Inhibitor Library drug discovery platform. The Company’s product pipeline includes Checkpoint Kinase 1, Aurora+FLT3 kinase, TYK2 kinase-autoimmune diseases and TYK2 kinase-cancer.

TypePublic
Founded2003
HQPampisford, GB
Websitesareum.com

Locations

Sareum Holdings is headquartered in
Pampisford, United Kingdom

Location Map

Latest Updates

Employees (est.) (Feb 2020)2
Revenue (FY, 2007)£2.5 M
Share Price (Jun 2020)£0 (-98%)
Cybersecurity ratingAMore

Key People/Management at Sareum Holdings

Stephen Parker Dphil

Stephen Parker Dphil

Non-Executive Chairman
John Reader

John Reader

Founder and CSO
Clive Birch

Clive Birch

Non-Executive Director
Show more

Sareum Holdings Office Locations

Sareum Holdings has an office in Pampisford
Pampisford, GB (HQ)
2a Langford Arch London Rd
Show all (1)

Sareum Holdings Financials and Metrics

Sareum Holdings Revenue

Sareum Holdings's revenue was reported to be £2.47 m in FY, 2007
GBP

Revenue (FY, 2007)

2.5m

Gross profit (FY, 2007)

618.1k

Gross profit margin (FY, 2007), %

25%

Net income (FY, 2007)

(527.4k)

EBIT (FY, 2007)

(734.6k)

Market capitalization (29-Jun-2020)

175.1k

Closing stock price (29-Jun-2020)

0.0

Cash (30-Jun-2019)

919.0k

EV

(743.9k)
Sareum Holdings's current market capitalization is £175.1 k.
GBPFY, 2007

Revenue

2.5m

Cost of goods sold

1.9m

Gross profit

618.1k

Gross profit Margin, %

25%
GBPFY, 2007FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

660.3k700.6k1.5m1.3m2.3m1.4m919.0k

Accounts Receivable

472.4k

Current Assets

1.5m1.1m1.7m1.5m2.4m1.8m1.2m
GBPFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash From Operating Activities

(785.3k)(644.2k)(678.0k)843.9k(1.6m)

Cash From Investing Activities

(970.8k)67.6k(592.7k)216.0k3.7k

Cash From Financing Activities

2.0m1.4m1.0m(6.9k)658.3k

Net Change in Cash

279.0k779.4k(227.4k)1.1m(930.2k)
Show all financial metrics

Sareum Holdings Cybersecurity Score

Cybersecurity ratingPremium dataset

A

91/100

SecurityScorecard logo

Sareum Holdings Online and Social Media Presence

Embed Graph

Sareum Holdings Frequently Asked Questions

  • When was Sareum Holdings founded?

    Sareum Holdings was founded in 2003.

  • Who are Sareum Holdings key executives?

    Sareum Holdings's key executives are Stephen Parker Dphil, John Reader and Clive Birch.

  • How many employees does Sareum Holdings have?

    Sareum Holdings has 2 employees.

  • What is Sareum Holdings revenue?

    Latest Sareum Holdings annual revenue is £2.5 m.

  • What is Sareum Holdings revenue per employee?

    Latest Sareum Holdings revenue per employee is £1.2 m.

  • Who are Sareum Holdings competitors?

    Competitors of Sareum Holdings include Akrevia Therapeutics, BerGenBio and Kiromic.

  • Where is Sareum Holdings headquarters?

    Sareum Holdings headquarters is located at 2a Langford Arch London Rd, Pampisford.

  • Where are Sareum Holdings offices?

    Sareum Holdings has an office in Pampisford.

  • How many offices does Sareum Holdings have?

    Sareum Holdings has 1 office.